Pergolide in Parkinson's Disease
- 1 December 1983
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 40 (13) , 785-787
- https://doi.org/10.1001/archneur.1983.04050120035003
Abstract
•Twenty-two patients received pergolide mesylate for Parkinson's disease for one year. Improvement was maximal at six months, but average functional scores were still better at 12 months than at pretreatment evaluation. On-off fluctuations were reduced in severity, and two of 18 patients experienced full resolution. Pergolide is an effective and safe ongoing medication for Parkinson's disease.This publication has 3 references indexed in Scilit:
- Treatment of advanced Parkinson disease with pergolideNeurology, 1981
- Analysis of the clinical problems in parkinsonism and the complications of long‐term levodopa therapyNeurology, 1979
- Five Years' Treatment of Parkinson's Disease with LevodopaAnnals of Internal Medicine, 1975